Cargando…
The Incidence of Amikacin Ototoxicity in Multidrug-ResistantTuberculosis Patients
Amikacin has been shown to irreversibly suppressCochlear activity.The aim of this study is to assess the incidence of amikacinototoxicity in multidrug-resistant tuberculosis patients and riskfactors associated withthis ototoxicity.In this cross-sectional study, 41 patientswith multidrug-resistant tu...
Autores principales: | Javadi, Mohammad Reza, Abtahi, Bahareh, Gholami, Kheirollah, Safari Moghadam, Behzad, Tabarsi, Payam, Salamzadeh, Jamshid |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Shaheed Beheshti University of Medical Sciences
2011
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3813070/ https://www.ncbi.nlm.nih.gov/pubmed/24250429 |
Ejemplares similares
-
Amikacin Concentrations Predictive of Ototoxicity in Multidrug-Resistant Tuberculosis Patients
por: Modongo, Chawangwa, et al.
Publicado: (2015) -
Sequential analysis as a tool for detection of amikacin ototoxicity in the treatment of multidrug-resistant tuberculosis
por: de Vasconcelos, Karla Anacleto, et al.
Publicado: (2018) -
Protective effect of creatine on amikacin-induced ototoxicity
por: Apaydın, Emre, et al.
Publicado: (2020) -
An Evaluation of the Protective Effects of Thymoquinone on Amikacin-Induced Ototoxicity in Rats
por: Aksoy, Fadlullah, et al.
Publicado: (2015) -
Effects of atorvastatin on plasma matrix metalloproteinase-9 concentration after glial tumor resection; a randomized, double blind, placebo controlled trial
por: Mohebbi, Niayesh, et al.
Publicado: (2014)